Revvity (RVTY) closed at $159.10 on November 10, 2026, down 1.0% from the previous close, on volume of 1,082,251 shares (30-day average 1,854,131).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 2, 2026 | Seagull With Put Spread | 20-Nov-26130 P : 150 P : 175 C | 1,800 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Catalyst Watch: Post-election positioning, Anthropic IPO buzz, and Adobe event
Seeking Alpha News (Fri, 6-Nov 3:00 PM ET)
Revvity (RVTY) lifts full-year outlook after pro forma revenue rises to $709.61 million
Market Chameleon (Tue, 3-Nov 2:38 AM ET)
Revvity Announces Financial Results for the Third Quarter of 2026
Business Wire (Tue, 3-Nov 6:00 AM ET)
Revvity Board Declares Quarterly Dividend
Business Wire (Fri, 30-Oct 4:05 PM ET)
Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
Business Wire (Tue, 20-Oct 8:00 AM ET)
Revvity to Present at Upcoming Investor Conferences
Business Wire (Tue, 13-Oct 8:00 AM ET)
Business Wire (Tue, 6-Oct 8:00 AM ET)
Revvity to Hold Earnings Call on November 3, 2026
Business Wire (Fri, 2-Oct 8:00 AM ET)
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
Business Wire (Thu, 24-Sep 8:00 AM ET)
Business Wire (Wed, 9-Sep 6:00 AM ET)
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Revvity trades on the NYSE stock market under the symbol RVTY.
As of November 11, 2026, RVTY stock price climbed to $159.52 with 600,682 million shares trading.
RVTY has a beta of 0.98, meaning it tends to be less sensitive to market movements. RVTY has a correlation of 0.10 to the broad based SPY ETF.
RVTY has a market cap of $17.80 billion. This is considered a Large Cap stock.
Last quarter Revvity reported $729 million in Revenue and $1.38 earnings per share. This beat revenue expectation by $32 million and exceeded earnings estimates by $.08.
In the last 3 years, RVTY traded as high as $171.74 and as low as $81.22.
The top ETF exchange traded funds that RVTY belongs to (by Net Assets): VTI, VOO, VB, RSP, VBR.
RVTY has outperformed the market in the last year with a return of +73.2%, while the SPY ETF gained +12.7%. In the last 3 month period, RVTY beat the market returning +37.6%, while SPY returned -1.4%. However, in the most recent 2 weeks RVTY has underperformed the stock market by returning -1.4%, while SPY returned -1.2%.
RVTY support price is $155.20 and resistance is $163.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RVTY shares will trade within this expected range on the day.
